0001731122-24-000266.txt : 20240216
0001731122-24-000266.hdr.sgml : 20240216
20240216093857
ACCESSION NUMBER: 0001731122-24-000266
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220722
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Binette Francois
CENTRAL INDEX KEY: 0001940686
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38758
FILM NUMBER: 24646027
MAIL ADDRESS:
STREET 1: 2022 N. ALVARADO STREET
CITY: LOS ANGELES
STATE: CA
ZIP: 90039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RENOVARO INC.
CENTRAL INDEX KEY: 0001527728
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452259340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 45 39179840
MAIL ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC.
DATE OF NAME CHANGE: 20230807
FORMER COMPANY:
FORMER CONFORMED NAME: Enochian Biosciences Inc.
DATE OF NAME CHANGE: 20230804
FORMER COMPANY:
FORMER CONFORMED NAME: Renovaro Biosciences Inc.
DATE OF NAME CHANGE: 20230802
3/A
1
ownership.xml
X0206
3/A
2022-07-22
2022-08-18
0
0001527728
RENOVARO INC.
RENB
0001940686
Binette Francois
C/O RENOVARO BIOSCIENCES INC.
9480 NE 2ND AVENUE #73
MIAMI
FL
33131
0
1
0
0
COO and Executive VP for R&D
Option to purchase shares of Common Stock
8.40
2023-04-18
2032-02-22
Common Stock
65000
D
The option was inadvertently omitted from the reporting person's original Form 3, and from the Form 4 filed by the reporting person after his original Form 3 was filed.
/s/ Francois Binette
2024-02-16